one
promis
vaccin
type
today
simplest
form
plasmid
contain
gene
pathogen
protein
element
need
transcrib
gene
mammalian
cell
dna
introduc
mammalian
cell
immun
transcrib
encod
antigen
synthes
initi
immun
respons
fig
unlik
vaccin
base
microbi
gene
tumor
antigen
advantag
synthes
specif
antigen
host
organ
process
correctli
induc
immun
respons
desir
specif
approach
promis
simplic
low
cost
product
transport
compar
tradit
vaccin
moreov
gene
engin
allow
easi
modif
new
antigen
design
properti
predict
silico
studi
use
caus
anxieti
possibl
genet
materi
get
insert
host
genom
insert
mutagenesi
howev
probabl
event
extrem
low
rang
around
insert
per
nuclei
lower
rate
natur
insert
mutat
factor
use
induc
protect
immun
respons
variou
infect
small
anim
rodent
larger
speci
seri
trial
prophylact
therapeut
variou
human
pathogen
includ
hcv
perform
howev
immunogen
genet
vaccin
need
improv
especi
human
applic
variou
approach
use
order
increas
effici
includ
develop
novel
method
administr
electropor
becom
increasingli
popular
recent
year
supplement
vaccin
formul
cytokin
andor
chemokin
gene
optim
plasmid
vector
select
effect
gene
promot
regulatori
element
modul
plasmid
cpg
content
also
modifi
code
sequenc
immunogen
often
chang
increas
express
one
promis
approach
modifi
immunogen
alter
process
present
pathway
achiev
label
protein
special
signal
sequenc
review
focus
signal
direct
protein
variou
cellular
compart
use
design
order
recogn
immun
system
antigen
must
process
present
surfac
cell
molecul
major
histocompat
complex
mhc
two
main
class
molecul
mhc
class
mhc
class
ii
order
bind
molecul
either
class
protein
encod
must
go
antigen
process
special
cell
compart
tabl
endogen
protein
degrad
proteasom
present
complex
cell
surfac
recogn
receptor
cytotox
ctl
initi
cytotox
immun
respons
exogen
protein
hydrolyz
proteas
lysosom
antigen
fragment
gener
process
bound
molecul
recogn
cell
facilit
cellular
well
humor
respons
thu
evid
process
pathway
immunogen
determin
type
immun
respons
induc
mention
earlier
process
antigen
via
pathway
result
process
involv
sever
step
fig
protein
synthes
cell
broken
small
peptid
proteasom
fragment
taken
associ
antigen
process
tap
protein
guid
peptid
endoplasm
reticulum
er
bind
molecul
complex
transport
cell
surfac
recogn
ctl
manifest
initi
cellular
respons
increas
amount
protein
transport
proteasom
er
principl
increas
present
via
pathway
henc
avail
cell
surfac
result
enhanc
cellular
respons
degrad
proteasom
protein
must
bear
specif
signal
chain
ubiquitin
molecul
ub
small
polypeptid
consist
amino
acid
residu
eukaryot
cell
special
group
enzym
recogn
protein
substrat
coval
attach
polyubiquitin
substrat
enzymat
group
call
system
system
recogn
variou
proteasom
degrad
signal
signal
repres
specif
amino
acid
sequenc
specif
pattern
protein
phosphoryl
alter
protein
structur
often
missfold
sever
degrad
signal
characterist
amino
acid
sequenc
describ
first
signal
discov
specif
first
amino
acid
residu
protein
serv
substrat
complex
cellular
enzym
respons
label
protein
polyubiquitin
chain
amino
acid
differ
capac
recogn
ubiquitin
enzym
tabl
also
degrad
signal
destruct
box
often
found
cellular
protein
tabl
natur
first
amino
acid
residu
protein
thu
one
main
protein
featur
determin
accumul
main
focu
research
antigen
target
proteasom
via
mechan
thought
provid
antigen
process
present
complex
enhanc
direct
achiev
clone
sequenc
onto
target
gene
ad
destabil
residu
ub
make
antigen
better
proteasom
substrat
cell
ub
cleav
posttransl
modif
chimer
protein
catalyz
ubiquitin
hydrolas
thu
expos
nef
modifi
way
gener
led
improv
immunogen
nef
mice
fusion
ubiquitin
use
immun
gene
express
librari
orf
open
read
frame
encod
plasmid
modifi
addit
ubiquitin
encod
sequenc
singl
immun
use
gene
gun
librari
stimul
strong
respons
antigen
respons
regist
enhanc
product
bind
addit
ubiquitin
synthet
protein
consist
hiv
also
result
increas
immunogen
prototyp
incorrect
protein
fold
also
act
proteasom
degrad
signal
use
increas
immunogen
influenza
viru
protein
unstabl
variant
construct
disrupt
region
via
introduct
short
foreign
amino
acid
sequenc
immun
gene
destructur
result
much
stronger
induc
origin
gene
howev
viral
protein
fusion
signal
result
increas
degrad
gag
protein
modifi
ubiquitin
destabil
arginin
residu
show
slight
increas
degrad
rate
effect
destabil
protein
requir
insert
addit
expos
lysin
residu
ek
chimera
effect
direct
proteasom
increas
present
peptid
complex
cell
surfac
howev
significantli
increas
mous
immun
also
enhanc
immunogen
perform
observ
similar
modif
express
nucleocapsid
core
protein
hepat
c
viru
hcv
hcv
core
gene
carri
cleavabl
well
uncleav
ubiquitin
residu
amino
acid
residu
equal
poor
immunogen
viral
model
describ
increas
proteasom
degrad
result
increas
protect
immun
notabl
protein
requir
ubiquitin
degrad
first
protein
discov
ornithin
decarboxylas
odc
degrad
antizym
bind
region
odc
direct
proteasom
antizym
releas
addit
site
odc
contain
also
experi
delet
mutant
odc
shown
minim
signal
requir
rapid
degrad
odc
proteasom
stretch
amino
acid
demonstr
region
requir
bind
odc
proteasom
system
mechan
complex
regul
use
protein
degrad
signal
direct
protein
proteasom
via
mechan
circumv
effect
multitud
factor
thu
provid
way
proteasom
target
fusion
revers
transcriptas
minim
signal
odc
repres
two
short
amino
acid
sequenc
odc
led
acceler
degrad
increas
immunogen
chimer
gene
mice
compar
origin
gene
modif
also
success
appli
weakli
immunogen
revers
transcriptas
help
enhanc
cellular
antibodi
immun
respons
mutant
enzym
form
process
antigen
via
pathway
involv
endoplasm
reticulum
er
increas
antigen
affin
toward
er
improv
immunogen
perform
antigen
protein
calreticulin
crt
abund
er
associ
compon
involv
present
antigen
via
pathway
fusion
calreticulin
tumor
antigen
use
improv
immun
respons
tumor
cell
encod
fusion
crt
protein
human
papilloma
viru
creat
mice
immun
exhibit
signific
increas
popul
lytic
activ
tumor
crt
anoth
protein
also
improv
immun
respons
mice
alter
local
protein
associ
increas
affin
er
also
achiev
differ
strategi
involv
antigen
fusion
extracellular
domain
tyrosin
kinas
ligand
fl
gene
fusion
introduc
subcutan
gene
gun
techniqu
led
consider
increas
capac
activ
specif
compar
unmodifi
gene
vitro
studi
show
cell
line
transfect
dna
present
antigen
complex
mhc
class
molecul
effect
cell
transfect
origin
gene
chimera
potent
activ
effect
depend
anoth
success
case
enhanc
immun
respons
manipul
report
envelop
protein
hepat
c
viru
effect
achiev
duplic
sequenc
promot
accumul
subsequ
releas
endoplasm
reticulum
peptid
bound
mainli
exogen
origin
captur
endocytosi
direct
lysosom
fig
howev
demonstr
intracellular
protein
present
result
autophagi
protein
transport
lysosom
via
transfer
carri
engulf
cytoplasm
lysosom
membran
format
autophagosom
transport
lysosom
antigen
cleav
acid
proteas
result
peptid
load
onto
molecul
brought
cell
surfac
cell
surfac
complex
recogn
receptor
lead
stimul
cellular
humor
immun
tradit
therapeut
vaccin
solubl
protein
antigen
aim
recruit
rel
weak
respons
one
weak
point
today
clinic
trial
also
shown
current
gener
induc
strong
antibodi
respons
therefor
target
antigen
present
pathway
order
activ
seem
especi
advantag
target
achiev
artifici
supplement
immunogen
lysosom
local
signal
specif
direct
lysosom
use
protein
sort
signal
intracellular
sort
signal
found
region
transmembran
protein
short
amino
acid
sequenc
divid
sequenc
signal
consensu
motif
npxi
yxx
x
amino
acid
amino
acid
larg
hydrophob
consensu
sequenc
dileucin
signal
de
xxxl
li
dxxll
signal
recogn
adaptor
protein
ap
relat
complex
direct
plasmat
membran
endosom
motif
cluster
acid
amino
acid
npfsd
sequenc
number
cellular
protein
direct
lysosom
due
presenc
phosphoryl
mannos
residu
attach
consensu
sequenc
nx
st
also
signal
seem
direct
cytoplasm
protein
lysosom
via
autophagosom
mechan
shown
dileucin
signal
effect
direct
heterolog
protein
lysosom
activ
use
signal
target
present
membran
protein
invari
chain
ii
bind
motif
lysosom
protein
limp
ii
sort
signal
protein
target
antigen
process
via
present
pathway
enhanc
present
shown
vitro
experi
mous
immun
experi
demonstr
chimera
induc
stronger
lymphoprolif
activ
higher
antibodi
titer
compar
nonmodifi
increas
immun
respons
respons
fusion
shown
immun
dna
encod
fusion
lampgag
stimul
prolong
respons
immun
respons
caus
inject
nonmodifi
gag
gene
rapidli
reced
anoth
success
redirect
cytoplasm
protein
nucleocapsid
protein
coronaviru
sar
sarsn
immun
mice
dna
encod
chimera
led
balanc
specif
product
strong
sarsn
also
fusion
revers
transcriptas
improv
immunogen
prototyp
viru
strong
immun
respons
mix
rais
wild
revers
transcriptas
circumv
toler
immun
system
toward
conserv
retrovir
antigen
fusion
increas
immunogen
dna
immunogen
encod
flaviviru
envelop
protein
candid
vaccin
dengu
viru
type
base
dna
encod
premembran
prem
envelop
e
transmembran
cytoplasm
domain
e
replac
similar
domain
chimera
exhibit
characterist
granular
cytoplasm
stain
indic
endogen
protein
observ
case
nonmodifi
antigen
mice
immun
gene
chimera
exhibit
much
higher
level
neutral
antibodi
control
receiv
parent
gene
similar
prototyp
design
west
nile
viru
case
premembran
envelop
wn
code
sequenc
fuse
sequenc
encod
transmembran
cytoplasm
domain
mice
immun
gene
wn
chimera
respond
product
high
titer
neutral
antibodi
dna
encod
origin
antigen
induc
antibodi
respons
altogeth
result
provid
basi
creat
panel
effect
flavivirus
introduct
protein
gene
fuse
sequenc
encod
also
increas
immun
respons
introduct
secretori
variant
form
recombin
viru
induc
strong
immun
respons
prevent
format
tumor
reduc
size
one
alreadi
present
howev
unsuccess
case
appli
modif
cytoplasm
protein
case
nucleocapsid
protein
hcv
plasmid
construct
express
chimer
fusion
protein
hcv
nuclecapsid
protein
sequenc
immun
mice
construct
lead
detect
antibodi
respons
cell
prolifer
induc
weak
thu
direct
lysosom
fuse
immunogen
necessarili
ensur
enhanc
type
immun
respons
molecul
requir
transport
lysosom
compart
transport
involv
invari
chain
mhc
class
ii
molecul
ii
two
sort
signal
found
cytoplasm
domain
ii
shown
endogen
synthes
protein
normal
present
via
pathway
effect
present
fuse
ii
numer
experi
anim
model
demonstr
fusion
recombin
antigen
ii
enhanc
broaden
prolong
protect
immun
respons
result
chimer
vitro
vivo
experi
shown
immunogen
base
adenoviru
express
fusion
ii
glycoprotein
lymphocyt
choriomening
viru
lcmv
increas
abil
stimul
moreov
mice
immun
plasmid
resist
infect
lethal
lcmv
dose
approach
also
effect
immun
larger
speci
made
encod
major
surfac
protein
anaplasma
marginal
fuse
motif
bovin
ii
direct
chimera
lysosom
compart
singl
dose
plasmid
effect
stimul
immun
respons
seen
potent
prolifer
product
specif
igg
singl
inject
construct
induc
antigen
specif
memori
cell
form
basi
acceler
respons
repeat
dose
antigen
precis
mechan
behind
autophagi
yet
unknown
despit
intens
ongo
studi
regard
antigen
retarget
shown
fusion
protein
influenza
viru
matrix
protein
lead
consider
increas
mhc
class
ii
present
respons
confirm
autophagi
constantli
effect
direct
cytoplasm
protein
present
via
mhc
class
ii
pathway
use
stimul
respons
effect
approach
induct
immun
respons
target
protein
secret
extracellular
environ
fusion
gag
e
protein
secretori
chemokin
direct
viral
protein
secretori
pathway
chimer
gene
induc
effect
product
antibodi
macaqu
macaqu
immun
chimera
infect
pathogen
lower
viral
load
infect
na
anim
exampl
convers
endogen
antigen
exogen
captur
endocytosi
transfer
lysosom
pathway
well
endogen
lysosom
target
enhanc
antigen
present
complex
mhc
class
ii
molecul
consider
increas
immunogen
today
mankind
face
acut
problem
creat
vaccin
hazard
diseas
hepat
c
immunodefici
caus
cancer
technolog
open
wide
rang
possibl
creat
effect
vaccin
one
immunogen
target
paper
review
number
signal
sequenc
introduc
immunogen
direct
predetermin
process
present
pathway
usual
differ
one
would
natur
take
direct
antigen
present
pathway
would
enhanc
cytotox
respons
direct
onto
pathway
would
activ
cell
stimul
cellular
humor
respons
overal
use
signal
sequenc
control
guid
immunogen
present
increas
immunogen
potenti
exist
help
creat
new
effect
prophylact
therapeut
vaccin
divers
human
applic
